Entrada Therapeutics TRDA
NASDAQ TRDA
$6.26 +0.00 (+0.00%)
As of: Sep 30, 2026 · 10:24 AM EDT

Entrada Therapeutics (TRDA) EV to EBITDA (2024 - 2025)

Updated

Entrada Therapeutics' EV to EBITDA came in at 35.03 for Q1 2025, up 131.1% from 15.16 a year earlier and up 224.2% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) EV to EBITDA (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Mar 31, 2025, Entrada Therapeutics reported EV to EBITDA of -11.38; for FY2024, it was 10.79.

  • Business Quant data shows TRDA's EV to EBITDA at 10.81 (Q4 2024), 8.48 (Q3 2024) and 3.56 (Q2 2024) in the three quarters before Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Entrada Therapeutics 242.19 Mn 242.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 35.03
Dec 31, 2024 10.81
Sep 30, 2024 8.48
Jun 30, 2024 3.56
Mar 31, 2024 15.16
API Access

Entrada Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TRDA&period=max&api_key=YOUR_API_KEY